Devens expansion completed by pharmaceuticals giant

August 31, 2016 by  

Two new buildings with a total of 200,000 square feet of space have recently been added to the Bristol-Myers Squibb (BMS) 89-acre campus in Devens.

One of the buildings is a Biologics Development Building where processes for the early production of investigational medicines take place. A Clinical Manufacturing Building is the other one for the production of these medicines for clinical trials.

According to the president of global manufacturing and supply at BMS, Lou Schmukler, bringing these two operations together on one campus will enable the development of these innovative medicines for patients around the world to be accelerated. In addition, more interaction among teams of employees working in the development of biologics processes, clinical manufacturing, and commercial manufacturing will be encouraged by means of pedestrian bridges among the buildings.

The addition of these two buildings now makes a total of eight buildings on the campus with 600,000 square feet of space. The expansion will also bring 200 jobs immediately to the area, with 150 more expected in the future. This is good news for business card printing companies in the area as these professionals will need business cards once they are hired.

The two buildings have several notable sustainable features, including water-efficient landscaping and high-efficiency lighting and water systems.

After winning $60m in local and state economic incentives in 2006, BMS agreed to build the biologics complex on the former United States Army base.